218 related articles for article (PubMed ID: 9928732)
1. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City.
Des Jarlais DC; Friedman SR; Perlis T; Chapman TF; Sotheran JL; Paone D; Monterroso E; Neaigus A
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Jan; 20(1):67-72. PubMed ID: 9928732
[TBL] [Abstract][Full Text] [Related]
2. The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.
Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Heckathorn DD; Mcknight C; Bramson H; Friedman SR
Addiction; 2007 May; 102(5):778-85. PubMed ID: 17506155
[TBL] [Abstract][Full Text] [Related]
3. High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs.
Uusküla A; Kals M; Rajaleid K; Abel K; Talu A; Rüütel K; Platt L; Rhodes T; Dehovitz J; Des Jarlais D
J Public Health (Oxf); 2008 Jun; 30(2):119-25. PubMed ID: 18308743
[TBL] [Abstract][Full Text] [Related]
4. Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991-1996.
Friedman SR; Chapman TF; Perlis TE; Rockwell R; Paone D; Sotheran JL; Des Jarlais DC
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):83-91. PubMed ID: 10534151
[TBL] [Abstract][Full Text] [Related]
5. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
[TBL] [Abstract][Full Text] [Related]
6. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.
Des Jarlais DC; Friedman SR; Sotheran JL; Wenston J; Marmor M; Yancovitz SR; Frank B; Beatrice S; Mildvan D
JAMA; 1994 Jan; 271(2):121-7. PubMed ID: 8264066
[TBL] [Abstract][Full Text] [Related]
7. "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.
Des Jarlais DC; Perlis T; Arasteh K; Hagan H; Milliken J; Braine N; Yancovitz S; Mildvan D; Perlman DC; Maslow C; Friedman SR
J Acquir Immune Defic Syndr; 2004 Feb; 35(2):158-66. PubMed ID: 14722449
[TBL] [Abstract][Full Text] [Related]
8. Changes in HIV prevalence and risk among new injecting drug users in a Russian city of high HIV prevalence.
Platt L; Rhodes T; Hickman M; Mikhailova L; Lisetsky K; Sarang A; Lewis K; Parry J
J Acquir Immune Defic Syndr; 2008 Apr; 47(5):623-31. PubMed ID: 18209680
[TBL] [Abstract][Full Text] [Related]
9. "Why I am not infected with HIV": implications for long-term HIV risk reduction and HIV vaccine trials.
Des Jarlais DC; Vanichseni S; Marmor M; Buavirat A; Titus S; Raktham S; Friedmann P; Kitayaporn D; Wolfe H; Friedman SR; Mastro TD
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Dec; 16(5):393-9. PubMed ID: 9420319
[TBL] [Abstract][Full Text] [Related]
10. Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States.
Vanichseni S; Des Jarlais DC; Choopanya K; Friedmann P; Wenston J; Sonchai W; Sotheran JL; Raktham S; Carballo M; Friedman SR
AIDS; 1993 Jun; 7(6):887-91. PubMed ID: 8363764
[TBL] [Abstract][Full Text] [Related]
11. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001.
Des Jarlais DC; Perlis T; Arasteh K; Torian LV; Hagan H; Beatrice S; Smith L; Wethers J; Milliken J; Mildvan D; Yancovitz S; Friedman SR
AIDS; 2005 Oct; 19 Suppl 3():S20-5. PubMed ID: 16251819
[TBL] [Abstract][Full Text] [Related]
12. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
[TBL] [Abstract][Full Text] [Related]
13. HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic.
Uusküla A; Raag M; Marsh K; Talu A; Vorobjov S; Des Jarlais D
PLoS One; 2017; 12(2):e0170956. PubMed ID: 28152026
[TBL] [Abstract][Full Text] [Related]
14. The role of "long-term" and "new" injectors in a declining HIV/AIDS epidemic in Rio de Janeiro, Brazil.
Hacker MA; Friedman SR; Telles PR; Teixeira SL; Bongertz V; Morgado MG; Bastos FI
Subst Use Misuse; 2005; 40(1):99-123. PubMed ID: 15702651
[TBL] [Abstract][Full Text] [Related]
15. First injection and current risk factors for HIV among new and long-term injection drug users.
Chitwood DD; Sanchez J; Comerford M; Page JB; McBride DC; Kitner KR
AIDS Care; 2000 Jun; 12(3):313-20. PubMed ID: 10928209
[TBL] [Abstract][Full Text] [Related]
16. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
[TBL] [Abstract][Full Text] [Related]
17. HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions.
Lima ES; Bastos FI; Telles PR; Friedman SR
Bull Narc; 1993; 45(1):107-15. PubMed ID: 8305901
[TBL] [Abstract][Full Text] [Related]
18. Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City.
Des Jarlais DC; Arasteh K; McKnight C; Hagan H; Perlman D; Friedman SR
Drug Alcohol Depend; 2009 Apr; 101(1-2):88-91. PubMed ID: 19108958
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviour.
Rhodes T; Hunter GM; Stimson GV; Donoghoe MC; Noble A; Parry J; Chalmers C
Addiction; 1996 Oct; 91(10):1457-67. PubMed ID: 8917914
[TBL] [Abstract][Full Text] [Related]
20. Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II.
Des Jarlais DC; Perlis TE; Stimson GV; Poznyak V;
BMC Public Health; 2006 Mar; 6():54. PubMed ID: 16512922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
